Lindbrook Capital’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.13K | Buy |
392
+9
| +2% | +$141 | ﹤0.01% | 1871 |
|
|
2024
Q4 | $5.34K | Buy |
383
+26
| +7% | +$362 | ﹤0.01% | 1956 |
|
|
2024
Q3 | $3.32K | Hold |
357
| – | – | ﹤0.01% | 2174 |
|
|
2024
Q2 | $3.32K | Sell |
357
-125
| -26% | -$1.16K | ﹤0.01% | 2176 |
|
|
2024
Q1 | $4.78K | Buy |
+482
| New | +$4.78K | ﹤0.01% | 1912 |
|
|
2023
Q4 | – | Sell |
-140
| Closed | -$743 | – | 2696 |
|
|
2023
Q3 | $743 | Buy |
140
+56
| +67% | +$297 | ﹤0.01% | 2436 |
|
|
2023
Q2 | $801 | Buy |
+84
| New | +$801 | ﹤0.01% | 2414 |
|
|
2022
Q4 | – | Sell |
-138
| Closed | -$3K | – | 2835 |
|
|
2022
Q3 | $3K | Buy |
138
+12
| +10% | +$261 | ﹤0.01% | 1834 |
|
|
2022
Q2 | $3K | Buy |
126
+10
| +9% | +$238 | ﹤0.01% | 1743 |
|
|
2022
Q1 | $2K | Buy |
+116
| New | +$2K | ﹤0.01% | 1934 |
|